Rare cancer drug to be subsidised – 7NEWS

A drug to treat a rare stomach and bowel cancer will be subsidised after being listed on the Pharmaceutical Benefits Scheme.
People suffering from advanced gastrointestinal stromal tumour will be able to buy the drug Qinlock for at most $41.30 per script…

Click here to view the original article.